NOT-AR-23-018: Notice of NIAMS Withdrawal from PA-20-194 "Parent R21 Exploratory/Developmental Grant, Clinical Trial Required"

Notice of NIAMS Withdrawal from PA-20-194 "Parent R21 Exploratory/Developmental Grant, Clinical Trial Required"

Notice Number:

NOT-AR-23-018

Key Dates

Release Date:

April 20, 2023

Related Announcements

PA-20-194 - Parent R21 Exploratory/Developmental Grant, Clinical Trial Required

Issued by

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Purpose

The purpose of this Notice is to inform prospective applicants that effective May 8, 2023, the NIAMS will withdraw from the Parent R21 Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Required) Notice of Funding Opportunity (NOFO) PA-20-194. NIAMS will only accept R21 applications in response to a Notice of Special Interest (NOSI).

Inquiries

Please direct all inquiries to:

Alexey Belkin, Ph.D.
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Telephone: 301-827-6475
Email: alexey.belkin@nih.gov